Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Short-term Investments: 2024

Historic Short-term Investments for Immunocore Holdings (IMCR) over the last 1 years, with Dec 2024 value amounting to $364.6 million.

  • Immunocore Holdings' Short-term Investments rose 8.37% to $393.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.9 million, marking a year-over-year increase of 8.37%. This contributed to the annual value of $364.6 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Immunocore Holdings reported Short-term Investments of $364.6 million as of FY2024.
  • In the past 5 years, Immunocore Holdings' Short-term Investments ranged from a high of $364.6 million in FY2024 and a low of $364.6 million during FY2024.
  • Its 1-year average for Short-term Investments is $364.6 million, with a median of $364.6 million in 2024.